| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Ludovic Samalin, Marion Garnier, Pierre-Michel Llorc. Clinical potential of lurasidone in the management of schizophrenia. Therapeutics and clinical risk management. vol 7. 2011-07-14. PMID:21753886. |
lurasidone is a new second-generation antipsychotic approved in october 2010 by the food and drug administration for the treatment of schizophrenia. |
2011-07-14 |
2023-08-12 |
Not clear |
| Lurasidone (Latuda) for schizophrenia. The Medical letter on drugs and therapeutics. vol 53. issue 1358. 2011-05-23. PMID:21372761. |
lurasidone (latuda) for schizophrenia. |
2011-05-23 |
2023-08-12 |
Not clear |
| Leslie Citrom. Lurasidone for schizophrenia: a brief review of a new second-generation antipsychotic. Clinical schizophrenia & related psychoses. vol 4. issue 4. 2011-03-08. PMID:21177242. |
lurasidone for schizophrenia: a brief review of a new second-generation antipsychotic. |
2011-03-08 |
2023-08-12 |
Not clear |
| Leslie Citrom. Lurasidone for schizophrenia: a brief review of a new second-generation antipsychotic. Clinical schizophrenia & related psychoses. vol 4. issue 4. 2011-03-08. PMID:21177242. |
lurasidone is a second-generation antipsychotic newly approved by the u.s. food and drug administration for the treatment of schizophrenia. |
2011-03-08 |
2023-08-12 |
Not clear |
| Jonathan M Meyer, Antony D Loebel, Edward Schweize. Lurasidone: a new drug in development for schizophrenia. Expert opinion on investigational drugs. vol 18. issue 11. 2010-02-25. PMID:19780705. |
lurasidone: a new drug in development for schizophrenia. |
2010-02-25 |
2023-08-12 |
Not clear |
| Jonathan M Meyer, Antony D Loebel, Edward Schweize. Lurasidone: a new drug in development for schizophrenia. Expert opinion on investigational drugs. vol 18. issue 11. 2010-02-25. PMID:19780705. |
lurasidone is a novel psychotropic agent in development for the treatment of schizophrenia and bipolar disorder. |
2010-02-25 |
2023-08-12 |
Not clear |
| Mitsutaka Nakamura, Masaaki Ogasa, John Guarino, Debra Phillips, Joseph Severs, Josephine Cucchiaro, Antony Loebe. Lurasidone in the treatment of acute schizophrenia: a double-blind, placebo-controlled trial. The Journal of clinical psychiatry. vol 70. issue 6. 2009-07-20. PMID:19497249. |
lurasidone in the treatment of acute schizophrenia: a double-blind, placebo-controlled trial. |
2009-07-20 |
2023-08-12 |
Not clear |
| Mitsutaka Nakamura, Masaaki Ogasa, John Guarino, Debra Phillips, Joseph Severs, Josephine Cucchiaro, Antony Loebe. Lurasidone in the treatment of acute schizophrenia: a double-blind, placebo-controlled trial. The Journal of clinical psychiatry. vol 70. issue 6. 2009-07-20. PMID:19497249. |
the objective of the study was to evaluate the safety and efficacy of lurasidone in patients hospitalized for an acute exacerbation of dsm-iv-defined schizophrenia. |
2009-07-20 |
2023-08-12 |
Not clear |
| Takeo Ishiyama, Kumiko Tokuda, Tadashi Ishibashi, Akira Ito, Satoko Toma, Yukihiro Ohn. Lurasidone (SM-13496), a novel atypical antipsychotic drug, reverses MK-801-induced impairment of learning and memory in the rat passive-avoidance test. European journal of pharmacology. vol 572. issue 2-3. 2008-01-14. PMID:17662268. |
these results suggest that lurasidone is superior to other antipsychotics in improving the mk-801-induced memory impairment and may be clinically useful for treating cognitive impairments in schizophrenia. |
2008-01-14 |
2023-08-12 |
rat |